Sign in

    Jon Rousseau

    Chairman, President, and Chief Executive Officer at Brightspring Health Services Inc
    Board
    Since September 2016
    Age
    50 years
    Education
    Earned an MBA from Harvard Business School and an A.B. degree from Princeton University.
    Tenure
    Joined in September 2016 as President and Chief Executive Officer and became Chairman of the board in January 2024.

    Also at Brightspring Health Services Inc

    BB
    Bob Barnes
    President of Community Living
    JP
    Jennifer Phipps
    Chief Financial Officer (CFO)
    JY
    Jennifer Yowler
    President of PharMerica

    About

    Jon Rousseau is the Chairman, President, and Chief Executive Officer at BrightSpring Health Services, Inc. His leadership started when he joined in September 2016 as President and CEO, a role in which he has driven significant strategic initiatives and operational growth.

    His extensive professional background includes senior roles at Kindred Healthcare, where he served in multiple leadership capacities, as well as impactful positions in companies such as Mylan, Inc. and Medtronic PLC. This diverse experience in the healthcare industry has been a key asset in guiding the company.

    Before his roles in healthcare, he built a solid foundation in finance by working in private equity and investment banking, experiences that enriched his analytical and strategic capabilities. His academic credentials, which include an MBA from Harvard Business School and an A.B. degree from Princeton University, further complement his extensive career in the industry.

    $BTSG Performance Under Jon Rousseau

    Past Roles

    OrganizationRoleDate Range
    Optum Inc. (UnitedHealth Group) Executive Vice President N/A [N/A]

    Fixed Compensation

    Data from  FY 2023
    Component NameAmount ($)Payment ScheduleAdditional Details
    Base Salary926,027AnnualIncludes salary increase effective May 16, 2023, raised from $800,000 to $1,000,000.
    Health Insurance Premiums1,687AnnualCost of health insurance premiums for 2023.
    Use of Private Plane51,522As IncurredCost associated with private plane usage.
    Stock Option Cancellation Payment10,000,000Lump Sum (November 2023)Cash payment for cancellation of 628,108 stock options: $3,437,500 for 215,912 shares held directly and $6,562,500 for 412,196 shares held in an irrevocable trust.
    Health & Welfare Benefits22,538Annual (Coverage for 18 months)Estimated COBRA medical insurance cost under 2023 rates for 18 months.

    Performance Compensation

    Data from  FY 2023

    Annual Cash Incentive Award (BHS STIC) for 2023

    Metric/DetailValue
    Performance Metrics & Weighting EBITDA: 50%, Quality & People: 30%, Efficiency: 10%, Revenue Growth: 10%
    Threshold Achievement91% of target (payout: 5% of target award)
    Target Achievement100% of target (payout: 100% of target award)
    Maximum Achievement120% of target (payout: 200% of target award)
    Minimum EBITDA Trigger90% (required for plan funding)
    Grant DateMay 11, 2023
    Payout AmountsThreshold: $31,250, Target: $1,250,000, Maximum: $2,500,000
    Actual OutcomePayout earned: $1,419,531 (114% of target award)

    Long-Term Equity Awards (2023 Grant Stock Options)

    Metric/DetailValue
    Grant DateNovember 22, 2023
    Grant Date Fair Value$5,949,200
    Exercise Price$22.29 per share
    Vesting ScheduleIf no IPO within six months: 100% vest on the six-month anniversary; if IPO occurs within six months: one-third at six months with remaining vesting monthly over two years
    Term10 years
    Performance Metrics/TargetsNot specified; vesting is time-based and contingent on corporate events

    Performance-Vesting Stock Options (2019 Grant)

    Metric/DetailValue
    Grant DateOctober 16, 2019
    Exercise Price$6.37 per share
    Vesting ConditionsVest when KKR Stockholder receives cash proceeds at 2.0x or 2.5x multiples on its investment
    Expiration DateOctober 16, 2029
    Additional Performance Metrics/TargetsSpecific performance thresholds not provided for 2023

    Severance Payments (Performance-Based)

    Metric/DetailValue/Details
    Triggering ConditionsTermination without cause, resignation for good reason, or non-renewal of the employment term
    Payout StructureEntitles Jon Rousseau to 2.0x his base salary and target incentive bonus, payable over two years
    Performance LinkageBonus is pro-rated based on actual performance for the year of termination
    Additional Vesting DetailsUnvested 2023 stock options become fully vested upon termination

    *All values and details are based on the 2023 data provided in the documents. *